THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to von Willebrand Factor

This is a "connection" page, showing publications James George has written about von Willebrand Factor.
Connection Strength

1.877
  1. Clinical insights from observations on ADAMTS13 deficiency in liver cirrhosis. Thromb Haemost. 2008 Jun; 99(6):987-8.
    View in: PubMed
    Score: 0.303
  2. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clin Adv Hematol Oncol. 2005 Aug; 3(8):627-32.
    View in: PubMed
    Score: 0.249
  3. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep. 2005 May; 4(3):167-9.
    View in: PubMed
    Score: 0.245
  4. Hereditary Thrombotic Thrombocytopenic Purpura. Genes (Basel). 2023 10 18; 14(10).
    View in: PubMed
    Score: 0.220
  5. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. Proc Natl Acad Sci U S A. 2022 08 23; 119(34):e2207592119.
    View in: PubMed
    Score: 0.203
  6. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91.
    View in: PubMed
    Score: 0.098
  7. ADAMTS13: what it does, how it works, and why it's important. Transfusion. 2009 Feb; 49(2):196-8.
    View in: PubMed
    Score: 0.079
  8. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica. 2008 Feb; 93(2):172-7.
    View in: PubMed
    Score: 0.074
  9. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Semin Hematol. 2004 Jan; 41(1):1-3.
    View in: PubMed
    Score: 0.056
  10. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.056
  11. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004; 407-23.
    View in: PubMed
    Score: 0.056
  12. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.052
  13. Deletion of platelet CLEC-2 decreases GPIba-mediated integrin aIIbß3 activation and decreases thrombosis in TTP. Blood. 2022 04 21; 139(16):2523-2533.
    View in: PubMed
    Score: 0.050
  14. Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002; 315-34.
    View in: PubMed
    Score: 0.049
  15. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021 04 08; 137(14):1855-1861.
    View in: PubMed
    Score: 0.046
  16. Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab. Am J Hematol. 2020 04; 95(4):E76-E77.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES